Partenaire privilégié de l'industrie cosmétique, pharmaceutique et chimique, StratiCELL, société fondée début 2005, caractérise l'inocuité et l'efficacité dermo-cosmétique de différents actifs et produits au moyen de modèles et de tests in vitro et ce, dans un environnement BPL.
L'activité de StratiCELL est axée sur la production et la commercialisation d'épidermes reconstitués, destinés aux tests in vitro. Par ailleurs, StratiCELL preste de nombreux services qui permettent de caractériser les produits à usage cutané.
Gene Expression Analysis
As an official Service Provider for Applied Biosystems, StratiCELL offers integrated genomic services based on TaqMan array technology, including cell/tissue culture, RNA extraction, cDNA synthesis, RT-PCR and data analysis and interpretation, leading to the design of further functional tests.
With this technology, up to 384 genes can be analyzed and quantified simultaneously by Real-Time PCR.
This low- to medium- throughput system allows for 1-8 samples to be run in parallel against TaqMan® Gene Expression Assay targets that are pre-loaded into each well of the array. The TaqMan® Custom Array is fully customizable.
Gene expression analysis in the skin
- ABI pre-designed TaqMan arrays;
- Several formats: 12, 16, 24, 32, 48, 64, 96, 192 or 394 genes including housekeeping control;
- StratiCELL predefined "Skin and Cosmetic" array ;
- StratiCELL predefined TaqMan arrays focused on 96 genes involved in the specific thematic;
- Fully customized TaqMan arrays to perfectly answer your needs.
TaqMan Array reaction set-up process
Gene expression analysis